Statins activate AMPK via mild mitochondrial stress, which Louis argues is beneficial
Louis argues statins do not harmfully impair mitochondria; instead, like metformin, they mildly stress mitochondria and activate the longevity-linked AMPK pathway (mitohormesis), possibly contributing to cardiovascular benefit. He cites a 2006 Circulation study showing statins activate AMPK in vitro and in vivo, leading to endothelial NO synthase activation. The extension to lifespan and mitohormesis is his interpretation.


